Complications Flashcards

(35 cards)

1
Q

Main type of complications

A

Acute: hypo + hyper (DKA + HHS)
Chronic: micro + macro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is level 1 hyperglycemia

A

BG bw 3-3.9
- autonomic symptoms; no neuroglycopenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Level 2 hypoglycemia

A

BG bw< 3
- have neuroglycopenic symtpoms +/- autonomic; no changes in mental or physical state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Level 3 hypoglycemia

A

neuroglycopenic symptoms + changes to mental/physical state
- may be unconscious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Level 1+2 treatment

A

15g of carbs, retest in 15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Level 3 treatment Conscious

A

20g of carbs OR 3mg of IN glucagon or 1mg glucagon SC/IM
- retest in 15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Level 3 treatment (unconscious)

A

3mg of IN glucagon or 1mg SC/IM
- or 10-25g of glucose IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T or F: DKA is more common in T2DM who are younger

A

F- more common in young T1DM

HHS: more common in elderly T2DM (less common overall than DKA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which hyperglycemic emergency has Kussman breathing ?

A

DKA: main features include acidosis, ketosis , and can have hyperglycemia (mild)
—- BG- 11.1
- + ketone

HHS: severe hyperglycemia —- start peeing out urine —- volume depletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

S+S of Retinopathy

A
  • seeing spots
    blurry vision
    blank spots in center of vision
  • difficulty seeing at night
  • fading colour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nephropathy S+S

A

normally asymptomatic
- increased ACR
- increased urination
- edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Neuropathy S+S

A

numbness, tingling of extremities
- burning or sharp pain

autonomic ones
- GI: gastroparesis, consitpation or diarrhea ( treat with pro kinetic as last restore)
CV: HR variability, tachy, postural hypo
Urinary: UTI, incontinence , EDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T or F: Diabetic retinopathy is more commonly seen in T2DM

A

F- T1DM and T2DM on insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Forms of retinopathy

A

1) Macular Edema: vascular leakage into macula
2)Non-proliferative + proliferative
3) Retinal Capillary Closure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do we screen for retinopathy + how often

A
  • dilated eye exam or retinal photography

T2DM: at diagnosis
T1DM: 5 years after diagnosis
—- if no R: screen every 1-2 yrs
— if R: screen every year
— if on semaglutide: every 6 mths

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the main factors that help prevent + slow progression of retinopathy

A

1) good A1c </= 7
2) BP 130/80
3) lipids: fenofibrate

17
Q

Treatment options for retinopathy

A

1) Pan-retinal photography/laser therapy: decrease swelling + stop BV leaking
2) VEGF anatagonists: Eylea
3) Vitrectomy/surgery: revolve scar tissue + blood

18
Q

How do we screen for neuropathy

A

monofilament or tuning fork

19
Q

What is the main way to prevent neuropathy

A

1glycemic control
—— prevent progression in T1DM with good glycemic control as well

20
Q

How common is diabetic neuropathy

A

40-50% of people with DM with get within 10 years of diagnosis

21
Q

Main treatment options for diabetic neuropathy

A

symptom management
- pregabalin 75mg BID (anticonvulsant)
- duloxetine 30mg once daily

other options: topical nitrates, opioids, TENS, capsaicin

** reduce pain by 30-50%

22
Q

What is the leading cause of ESRD

23
Q

what is nephropathy

A

progressive increase in proteinuria in people with DM —- decrease in kidney fxn

24
Q

How to screen for nephropathy

A

random ACR + eGFR
— if ACR + eGFR are in range (>2 and then < 60 for eGFR)—— no CKD , rescreen in 1 yr

—- if one of them is abnormal : eGFR< 60 or ACR>/=2: look to see if ACR >/=20 —- if so—- CKD
—- if not and eGFR <60 OR ACR bw 2-20: repeat SCr in 3 mths + also complete 2 more ACR tests over the span of next 3 mths

—CKD diagnosis if patterns still remain: eGFR still below 60 or 2/3 past ACR tests >/=2

25
What are the main things to help prevent nephropathy onset + progression
good A1c control + BP control + use of Acei/ARB (slow progression of CKD no matter what base BP is )
26
What can cause a transient increase in albumin in urine
recent exercise, UTI, febrile illness, period,
27
What are the 3 macrovascular complications
1) Cerebrovascular disease (CVD): brain problems such as stroke/TIA 2) Coronary Heart disease: HA, unstable angina or ACS 3) Peripheral vascular disease: ulcers, amputations, claudication
28
What are the key ABCDES of CV protection
1) A1c 50% 3) drugs to protect hear: Acei/ARB, statin, SGLT2/GLP-1a 4) exercise and healthy eating 5) smoking cessation ** controlling all these things not only decreases risk of CVD, mortality or other CVEs, but also all the micro complications
29
T or F: statins only work slow the progression of CVD and have no impact on primary prevention (stopping people from have macrovascular complications)
F- statins have prevent and slow progression of macrovascular complications
30
Criteria for statin
One of the following - age >/=40 - clinical CVD - Microvascular complication (R, nephro, or neuro) - diabetic for over > 15 yrs and age > 30 - meet criteria for treatment based on dyslipidemia guidelines
31
Criteria for ACEi or ARB therapy
1 of the following - age >/= 55 + additional CV RF (HTN, dyslipidemia, smoking, obese) - clinical CVD - microvascular complications (neuro, nephro, or retinopathy)
32
Dosing for statins for CV protection
- atorvastatin 10mg - rosuvastatin 20 mg
33
What ACEi/ARBs have evidence having CV protection
perindopril 8mg ramipril 10mg telmisartan 80mg
34
T or F: Acei/ARBs offer primary prevention of CVD (stop you from getting macro complications) AND secondary prevention (slow progression of macrovascular complications if already have)
T
35
T or F: ASA offers primary and secondary CV protection
F - only use as secondary prevention in these with history of CVD